[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2446110A1 - INTERFERON INDUCER USEFUL AS A MEDICAMENT AND METHOD FOR ITS PREPARATION - Google Patents

INTERFERON INDUCER USEFUL AS A MEDICAMENT AND METHOD FOR ITS PREPARATION

Info

Publication number
FR2446110A1
FR2446110A1 FR8000473A FR8000473A FR2446110A1 FR 2446110 A1 FR2446110 A1 FR 2446110A1 FR 8000473 A FR8000473 A FR 8000473A FR 8000473 A FR8000473 A FR 8000473A FR 2446110 A1 FR2446110 A1 FR 2446110A1
Authority
FR
France
Prior art keywords
interferon inducer
medicament
preparation
useful
absorption spectrum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8000473A
Other languages
French (fr)
Other versions
FR2446110B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kitasato Institute
Original Assignee
Kitasato Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP54001540A external-priority patent/JPS6011891B2/en
Priority claimed from JP16008979A external-priority patent/JPS5683496A/en
Application filed by Kitasato Institute filed Critical Kitasato Institute
Publication of FR2446110A1 publication Critical patent/FR2446110A1/en
Application granted granted Critical
Publication of FR2446110B1 publication Critical patent/FR2446110B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne l'industrie pharmaceutique. On extrait des tissus d'un végétal appartenant au genre Artemisia de la famille des Composées ou de variants correspondants, de préférence par extraction par l'eau suivie d'une récupération pouvant être effectuée par ultrafiltration, un inducteur d'interféron caractérisé par l'analyse élémentaire suivante : H : 7,4 +- 0,4 %; C : 45,6 +- 0,4 %; N = 13,5 +- 0,4 %; P : 2,8 +- 0,3 %, un poids moléculaire d'environ 100 000 à environ 3 000 000 (principalement 500 000 à environ 1 000 000), son spectre d'absorption ultraviolet et son spectre d'absorption infrarouge. L'inducteur d'interféron est utile comme médicament pour la prévention et le traitement de diverses affections virales de l'homme et des animaux.The invention relates to the pharmaceutical industry. Tissues are extracted from a plant belonging to the genus Artemisia of the Compound family or from corresponding variants, preferably by extraction with water followed by recovery which can be carried out by ultrafiltration, an interferon inducer characterized by the following elemental analysis: H: 7.4 + - 0.4%; C: 45.6 + - 0.4%; N = 13.5 + - 0.4%; P: 2.8 + - 0.3%, a molecular weight of about 100,000 to about 3,000,000 (mainly 500,000 to about 1,000,000), its ultraviolet absorption spectrum and its infrared absorption spectrum. The interferon inducer is useful as a medicament for the prevention and treatment of various viral diseases in humans and animals.

FR8000473A 1979-01-10 1980-01-10 INTERFERON INDUCER USEFUL AS A MEDICAMENT AND METHOD FOR ITS PREPARATION Granted FR2446110A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP54001540A JPS6011891B2 (en) 1979-01-10 1979-01-10 Method for producing interferon inducer
JP16008979A JPS5683496A (en) 1979-12-10 1979-12-10 Interferon inducer and its preparation

Publications (2)

Publication Number Publication Date
FR2446110A1 true FR2446110A1 (en) 1980-08-08
FR2446110B1 FR2446110B1 (en) 1983-07-08

Family

ID=26334774

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8000473A Granted FR2446110A1 (en) 1979-01-10 1980-01-10 INTERFERON INDUCER USEFUL AS A MEDICAMENT AND METHOD FOR ITS PREPARATION

Country Status (3)

Country Link
DE (1) DE3000521A1 (en)
FR (1) FR2446110A1 (en)
GB (1) GB2042555B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0030812A2 (en) * 1979-12-03 1981-06-24 Kitasato Kenkyusho A process for preparing substances having interferon inducing activity and interferon inducers
FR2623397A1 (en) * 1987-11-19 1989-05-26 Cosnier Alain Plant-based medicinal composition for internal use
EP0568001A2 (en) * 1992-04-27 1993-11-03 Showa Shell Sekiyu Kabushiki Kaisha Antiviral agent containing crude drug

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3004018A1 (en) * 1979-02-07 1980-08-21 Kitasato Inst SUBSTANCE WITH INTERFERON INDUCING ACTIVITY AND METHOD FOR THEIR PRODUCTION
DE3070086D1 (en) * 1979-12-03 1985-03-14 Kitasato Inst A process for preparing substances having interferon inducing activity
DE4447588C2 (en) * 1994-05-03 1997-11-20 Omer Osama Dr Dr Med Treatment of herpes and hepatitis virus infections and bronchitis
DE10144765A1 (en) * 2001-09-11 2003-04-30 Horst Mayer Extract available from Artemisia abrotanum L. (Eberraute)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0030812A2 (en) * 1979-12-03 1981-06-24 Kitasato Kenkyusho A process for preparing substances having interferon inducing activity and interferon inducers
EP0030812A3 (en) * 1979-12-03 1981-07-15 Kitasato Kenkyusho A process for preparing substances having interferon inducing activity and interferon inducers
FR2623397A1 (en) * 1987-11-19 1989-05-26 Cosnier Alain Plant-based medicinal composition for internal use
EP0568001A2 (en) * 1992-04-27 1993-11-03 Showa Shell Sekiyu Kabushiki Kaisha Antiviral agent containing crude drug
US5411733A (en) * 1992-04-27 1995-05-02 Hozumi; Toyoharu Antiviral agent containing crude drug
EP0568001A3 (en) * 1992-04-27 1995-07-05 Tsuneo Namba Antiviral agent containing crude drug.

Also Published As

Publication number Publication date
DE3000521A1 (en) 1980-07-24
GB2042555A (en) 1980-09-24
FR2446110B1 (en) 1983-07-08
GB2042555B (en) 1983-03-09

Similar Documents

Publication Publication Date Title
BE901915A (en) PROCESS FOR THE TREATMENT OR PREVENTION OF DISEASES CAUSED BY ACETHER OF THE PLATELET ACTIVATION FACTOR.
GB1446284A (en) Neurotoxin
FR2386527A1 (en) NEWS 2-ALKYLENEAMINODIHYDROPYRIDINES, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM
FR2446110A1 (en) INTERFERON INDUCER USEFUL AS A MEDICAMENT AND METHOD FOR ITS PREPARATION
DE68929388D1 (en) Anticoagulant compound isolated from urine
BE899812A (en) PROCESS FOR THE PREPARATION OF PROTEIN CONCENTRATES AND NUTRIENT PRODUCTS BY TREATMENT OF ANIMAL BLOOD.
SE8104482L (en) PROCEDURE FOR PREPARING A FACTOR VIII (AHF) HIGH CONCENTRATE
EP0308197A3 (en) Method for stimulating the immune system
FR2442633A1 (en) INTERFERON INDUCERS AND THEIR MANUFACTURING METHOD
DE3780814D1 (en) USE OF NUCLEOSIDES FOR PRODUCING A MEDICINAL PRODUCT FOR TREATING DISEASES CAUSED BY A RETROVIRUS OR THE HEPATITIS B VIRUS.
JPS6456699A (en) Method for obtaining alpha 1-antitrypsin concentrate from human plasma and its utilization as drug
DE98814T1 (en) ANTITHROMBIN-HEPARIN COMPLEX.
DE68909019D1 (en) Anti-virus composition and its uses.
FR2536751B1 (en) NOVEL TRICYCLOPHOSPHAZENES DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
EP0286869B1 (en) Process for the preparation of cell wall components from halobacteria, and their use as medicaments
BE903168A (en) NEW 6-SUBSTITUTED MITOMYCIN ANALOGS
Lucero et al. Immunosuppressive properties of purified immune T-interferon
KR910000172A (en) Aggression from South America leech hementeria giuliani
Exon et al. Immunotoxicologic evaluation of chlorine-based drinking water disinfectants, sodium hypochlorite and monochloramine
JPS57112331A (en) Medical composition of ganoderma lucidum component
BE1002624A5 (en) COMPOSITIONS FOR THE TREATMENT OF PHLEBECTASIA AND THEIR PREPARATION METHOD.
ATE164882T1 (en) METHOD FOR PRODUCING ACTIVATED KILLER MONOCYTES AND METHOD FOR CHECKING THEIR TUMORICIDAL ACTIVITY
FR2448350A1 (en) INTERFERON INDUCER AND MANUFACTURING METHOD THEREOF
EP0383481A3 (en) Anesthetic oral compositions
DE3275060D1 (en) Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs

Legal Events

Date Code Title Description
ST Notification of lapse